Rajat Desikan, PhD (he/him/his)

Director
GSK (UK)
Rotherham, England, United States

Director, Clinical Pharmacology Modelling and Simulations, at GSK, involved in the development of several early and late stage clinical assets. Computational biologist, modeler, and clinical pharmacologist with 14 years of research experience. Core expertise in computational and quantitative systems pharmacology modelling within the therapeutic areas of infectious diseases, vaccines, and immunology. Liaised with cross-functional teams of chemists, biologists, clinicians, modelers, statisticians, clinical pharmacologists, pharmacometricians, software teams, and external academic collaborators. Mentored interns, graduate and undergraduate students, postdocs, and junior collaborators.

Disclosure information not submitted.

Presentation(s):

• Strategies for Selecting Explanatory Variables in Exposure-Response Analysis Using Machine Learning

  Wednesday, October 22, 2025
  8:00 AM - 12:00 PM MDT

• Machine learning applied to Hepatitis B virtual patients suggests prognostic biomarker signatures for stratifying responders to standard-of-care therapies.

  Wednesday, October 22, 2025
  10:15 AM - 10:45 AM MDT